Cogent Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.About COGT
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.
CEOAndrew R. Robbins
CEOAndrew R. Robbins
Employees205
Employees205
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2014
Founded2014
Employees205
Employees205
COGT Key Statistics
Market cap865.31M
Market cap865.31M
Price-Earnings ratio-3.12
Price-Earnings ratio-3.12
Dividend yield—
Dividend yield—
Average volume2.68M
Average volume2.68M
High today$7.73
High today$7.73
Low today$7.27
Low today$7.27
Open price$7.49
Open price$7.49
Volume1.86M
Volume1.86M
52 Week high$12.61
52 Week high$12.61
52 Week low$3.72
52 Week low$3.72
Analyst ratings
75%
of 12 ratingsBuy
75%
Hold
25%
Sell
0%
People also own
Based on the portfolios of people who own COGT. This list is generated using Robinhood data, and it’s not a recommendation.